We are live on
!
Find out more
State Street SPDR S&P Pharmaceuticals ETF
XPH
XPH
77 hedge funds and large institutions have $144M invested in State Street SPDR S&P Pharmaceuticals ETF in 2025 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
183% more call options, than puts
Call options by funds: $3.41M | Put options by funds: $1.2M
114% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 7
42% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 19
12% more funds holding
Funds holding: 69 → 77 (+8)
9% more capital invested
Capital invested by funds: $132M → $144M (+$11.9M)
12.78% less ownership
Funds ownership: 75.41% → 62.63% (-13%)
Holders
77
Holders Change
+8
Holders Change %
+11.59%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
27
Reduced
19
Closed
7
Calls
$3.41M
Puts
$1.2M
Net Calls
+$2.21M
Net Calls Change
+$2.7M
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$6.84M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$3.37M |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
+$2.56M |
| 4 |
Jane Street
New York
|
+$1.33M |
| 5 |
LPL Financial
San Diego,
California
|
+$1.26M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$21M |
| 2 |
Goldman Sachs
New York
|
-$4.18M |
| 3 |
JP Morgan Chase
New York
|
-$2.65M |
| 4 |
CI
CX Institutional
Auburn,
Indiana
|
-$2.26M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.93M |
